A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response

• Sanjay Chandriani,

  Current address: George Williams Hooper Research Foundation, University of California San Francisco, San Francisco, California, United States of America

  Affiliation Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America

  ⨯
• Eirik Frengen,

  Affiliations Department of Genetics and Pathology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Medical Genetics, Ullevål University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Victoria H. Cowling,

  Current address: College of Life Sciences, Division of Cell Biology & Immunology, University of Dundee, Dundee, United Kingdom

  Affiliation Department of Pharmacology and Toxicology, Dartmouth Medical School, Lebanon, New Hampshire, United States of America

  ⨯
• Sarah A. Pendergrass,

  Affiliation Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire, United States of America

  ⨯
• Charles M. Perou,

  Affiliation Department of Genetics and Pathology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Michael L. Whitfield,

  Affiliation Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire, United States of America

  ⨯
• Michael D. Cole

  * E-mail: michael.d.cole@dartmouth.edu

  Affiliations Department of Pharmacology and Toxicology, Dartmouth Medical School, Lebanon, New Hampshire, United States of America, Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire, United States of America

  ⨯